A61K 31/4045
Indole-alkylamines
Official title: Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
A61K31/4045 (Indole-alkylamines) appears on 1,293 US grants and 2,773 published applications in this corpus.
Search patents in A61K- Granted patents
- 1,293
- Published applications
- 2,773
- Assignees
- 1,127
- Inventors
- 4,357
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 3 | 0 |
| 1996 | 3 | 0 |
| 1997 | 9 | 0 |
| 1998 | 20 | 0 |
| 1999 | 19 | 0 |
| 2000 | 21 | 0 |
| 2001 | 23 | 12 |
| 2002 | 23 | 39 |
| 2003 | 21 | 43 |
| 2004 | 9 | 40 |
| 2005 | 8 | 45 |
| 2006 | 7 | 32 |
| 2007 | 6 | 43 |
| 2008 | 4 | 50 |
| 2009 | 13 | 44 |
| 2010 | 14 | 51 |
| 2011 | 19 | 66 |
| 2012 | 19 | 50 |
| 2013 | 35 | 84 |
| 2014 | 45 | 121 |
| 2015 | 60 | 125 |
| 2016 | 65 | 132 |
| 2017 | 92 | 145 |
| 2018 | 82 | 115 |
| 2019 | 86 | 132 |
| 2020 | 85 | 145 |
| 2021 | 66 | 144 |
| 2022 | 90 | 230 |
| 2023 | 83 | 244 |
| 2024 | 98 | 229 |
| 2025 | 95 | 259 |
| 2026 | 69 | 153 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method and apparatus for delivering an API-containing liquid to an edible substrate6 Oct 2026US 12,751,915 B2Transport Authority, Inc.
- Methods for delivery of psychedelic medications by inhalation and systems for performing the methods6 Oct 2026US 12,751,940 B2Cybin IRL Limited
- Pharmaceutical kits and uses thereof for treating colorectal cancer29 Sep 2026US 12,746,226 B2Anbogen Therapeutics, Inc
- Transmucosal film for treating insomnia15 Sep 2026US 12,734,127 B1Xiamen LP Pharmaceutical Co., Ltd.
- Non-hormonal treatment of hot flashes15 Sep 2026US 12,734,151 B1
- Method and pharmaceutical composition for treating a sleep disorder8 Oct 2026US 2026/0306442 A1Overseas Pharmaceuticals, Ltd.
- 5-methoxy-n,n-dimethyltryptamine (5-meo-dmt) pharmaceutical compositions8 Oct 2026US 2026/0306452 A1Beckley Psytech Limited
- Formulations containing tryptamine derivatives and uses thereof8 Oct 2026US 2026/0306453 A1Psilera Inc.
- N-n-dimethyltryptamine (dmt) and dmt analog oral transmucosal film compositions, methods of making, and methods of use thereof8 Oct 2026US 2026/0306454 A1
- Composition for removing and inhibiting senescent cells, and uses thereof8 Oct 2026US 2026/0306460 A1Lifeceutix Co., Ltd.
Most cited
By later US patents
- Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions198US 7,048,906 B2Cedars-Sinai Medical Center · 2006
- Topical administration of catecholamines and related compounds to subcutaneous muscle tissue using percutaneous penetration enhancers164US 5,879,690 A1999
- Pharmaceutical composition containing acid addition salt of basic drug163US 6,255,502 B1Farmarc Nederland BV · 2001
- Modulators of ATP-binding cassette transporters157US 7,495,103 B2Vertex Pharmaceuticals Incorporated · 2009
- Urologic irrigation solution and method for inhibition of pain, inflammation and spasm152US 5,858,017 AOmeros Medical Systems, Inc. · 1999